Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,117 | 1,249 | 95.2% |
| Consulting Fee | $660.00 | 2 | 2.8% |
| Education | $413.35 | 8 | 1.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39.90 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $3,015 | 154 | $0 (2024) |
| EMD Serono, Inc. | $2,409 | 102 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $2,265 | 71 | $0 (2024) |
| ABBVIE INC. | $1,587 | 129 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,195 | 72 | $0 (2024) |
| Lilly USA, LLC | $1,123 | 69 | $0 (2024) |
| TG Therapeutics, Inc. | $758.18 | 29 | $0 (2024) |
| PFIZER INC. | $715.26 | 68 | $0 (2024) |
| UCB, Inc. | $715.13 | 38 | $0 (2024) |
| Eisai Inc. | $693.44 | 43 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,846 | 302 | Alexion Pharmaceuticals, Inc. ($1,316) |
| 2023 | $6,675 | 361 | Biogen, Inc. ($801.80) |
| 2022 | $5,325 | 292 | Biogen, Inc. ($951.01) |
| 2021 | $4,384 | 306 | Biogen, Inc. ($925.27) |
All Payment Transactions
1,261 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Neurology | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: PAIN | ||||||
| 12/18/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Neuroscience | ||||||
| 12/17/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Neurology | ||||||
| 12/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.13 | General |
| 12/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $0.79 | General |
| 12/04/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $21.13 | General |
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.58 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $0.06 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: EPILEPSY | ||||||
| 12/02/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/26/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.30 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $1.37 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Rare Disease | ||||||
| 11/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $95.74 | General |
| Category: Rare Disease | ||||||
| 11/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| 11/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $6.18 | General |
About Melissa Ochoa, NP
Melissa Ochoa, NP is a Obstetric, Inpatient healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1730435546.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Ochoa, NP has received a total of $23,230 in payments from pharmaceutical and medical device companies, with $6,846 received in 2024. These payments were reported across 1,261 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($22,117).
Practice Information
- Specialty Obstetric, Inpatient
- Other Specialties Inpatient|Family
- Location Winchester, VA
- Active Since 07/30/2012
- Last Updated 02/04/2013
- Taxonomy Code 163WX0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730435546
Products in Payments
- TYSABRI (Biological) $2,086
- ULTOMIRIS (Biological) $1,613
- NURTEC ODT (Drug) $1,198
- BRIUMVI (Drug) $758.18
- VYEPTI (Biological) $671.57
- EMGALITY (Drug) $644.64
- APTIOM (Drug) $579.81
- UBRELVY (Drug) $578.03
- Gamunex-C (Biological) $479.08
- Leqembi (Drug) $464.14
- KESIMPTA (Drug) $443.84
- QULIPTA (Drug) $438.63
- MAVENCLAD (Drug) $413.47
- AJOVY (Biological) $401.25
- RYTARY (Drug) $369.65
- AMYVID (Drug) $360.06
- Austedo XR (Drug) $345.71
- SOLIRIS (Biological) $345.12
- RADICAVA (Drug) $337.83
- ZEPOSIA (Drug) $295.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.